China Advances Tokenized Bond Infrastructure as Regulators Tighten Stance on Stablecoins

– China issues $600M tokenized bonds to advance its CBDC-based financial framework – Regulators intensify crackdowns as stablecoin and crypto speculation reappear – Yuan management and FX intervention add pressure alongside digital-asset controls China expanded its state-directed digital-asset infrastructure this week as Hua Xia Bank issued 4.5 billion yuan ($600 million) in tokenized bonds while […]

Cloudflare Hit by Second Outage in Weeks, Shutting Down Crypto Exchanges Websites

– Cloudflare’s outage pushed major crypto platforms offline and exposed critical dependence on centralized web infrastructure – Exchanges and Solana protocols faced service failures as users struggled with login errors – Cloudflare later confirmed an internal firewall update caused the disruption Cloudflare (NYSE: $NET) suffered another major outage on Dec. 5, less than a month

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against MoonLake Immunotherapeutics (NASDAQ: MLTX)

(NASDAQ:MLTX), NEW YORK, Dec. 05, 2025 (GLOBE NEWSWIRE) — Bernstein Liebhard LLP, announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or acquired the common stock of MoonLake Immunotherapeutics (“MoonLake” or the “Company”) (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, inclusive. Should

Jericho Project 2025 Day of Action Brings Holiday Cheer to Formerly Homeless New Yorkers Across the City

Annual event raises awareness of the challenges of homelessness and housing insecurity while lifting residents' spirits with holiday celebration Jericho Project, a nationally-acclaimed nonprofit ending homelessness at its roots, is launching its 2025 Day of Action on Friday, December 5, bringing together volunteers across the city to brighten the holiday season at Jericho's residences and

Clinical Chemistry Analyzers Market worth $20.86 billion by 2030 | MarketsandMarkets™

According toMarketsandMarkets™, the clinical chemistry analyzers market is projected to grow from USD 25.92 billion in 2025 to USD 20.86 billion by 2030, at a CAGR of 5.6%. https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg Browse270 market data Tables and50 Figures spread through235 Pages and in-depth TOC on”Clinical Chemistry Analyzers Market Clinical Chemistry Analyzers Market Size & Forecast: — Market Size

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against MoonLake Immunotherapeutics (NASDAQ: MLTX)

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against MoonLake Immunotherapeutics (NASDAQ: MLTX) GlobeNewswire December 05, 2025 NEW YORK, Dec. 05, 2025 (GLOBE NEWSWIRE) — Bernstein Liebhard LLP, announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the “Class”) who purchased or

CORRECTION – Massey Ferguson Names Prescott Frontier Days 2025 Sowing Good Deeds Winner

(NYSE:AGCO), In a release issued under the same headline on Dec. 4, 2025 by AGCO Corporation, please note that the quote in paragraph 5 was attributed to the wrong person. The corrected release follows: LAS VEGAS, Dec. 05, 2025 (GLOBE NEWSWIRE) — AGCO Corporation (NYSE: AGCO), a global leader in the design, manufacture and distribution

ApexPoint LLC Unveils New AI-Powered Investment Platform Designed to Enhance Trading Efficiency Across Global Financial Markets

New York, NY , Dec. 05, 2025 (GLOBE NEWSWIRE) — ApexPoint LLC, a private investment and technology firm specializing in cryptocurrency, stock, forex, and futures market strategies, today announced the official launch of its next-generation investment platform. The new platform blends AI-driven analytics, professional market insights, and streamlined digital tools that aim to help traders

Gelteq Preclinical Study Demonstrates Enhanced Oral Delivery of Oil-Soluble and Poorly Soluble Drugs Using Its Gel-Based Platform

(NASDAQ:GELS), MELBOURNE, Australia, Dec. 05, 2025 (GLOBE NEWSWIRE) — Gelteq Limited (“Gelteq” or the “Company”), a clinical and science-based developer of advanced gel-based oral delivery systems, today announced preclinical findings demonstrating the effectiveness, flexibility, and safety profile of its proprietary gel platform. The results address a major challenge in pharmaceutical development and demonstrate that Gelteq's

Scroll to Top